Design and immunogenicity of SARS-CoV-2 DNA vaccine encoding RBD-PVXCP fusion protein
D. Dormeshkin, M. Katsin, M. Stegantseva, S. Golenchenko, M. Shapira, S. Dubovik, D. Lutskovich, A. Kavaleuski, A. Meleshko, Vaccines 11 (2023).